A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB

NCT05484466 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: ZM-H1505R
OTHER: ZM-H1505R placebo
COMBINATION_PRODUCT: Baraclude

Sponsor

Shanghai Zhimeng Biopharma, Inc.

Collaborators

[object Object]